Barbara Jereczek-Fossa to Radiosurgery
This is a "connection" page, showing publications Barbara Jereczek-Fossa has written about Radiosurgery.
Connection Strength
5.055
-
Stereotactic body radiation therapy for mediastinal lymph node metastases: how do we fly in a 'no-fly zone'? Acta Oncol. 2018 Nov; 57(11):1532-1539.
Score: 0.596
-
Ablative stereotactic radiotherapy for oligometastatic colorectal cancer: Systematic review. Crit Rev Oncol Hematol. 2018 Sep; 129:91-101.
Score: 0.584
-
"Give me five" ultra-hypofractionated radiotherapy for localized prostate cancer: non-invasive ablative approach. Med Oncol. 2018 May 10; 35(6):96.
Score: 0.580
-
Stereotactic Body Radiation Therapy for Oligometastatic Ovarian Cancer: A Step Toward a Drug Holiday. Int J Radiat Oncol Biol Phys. 2018 07 01; 101(3):650-660.
Score: 0.576
-
CyberKnife radiotherapy for orbital metastases: A single-center experience on 24 lesions. Eur J Ophthalmol. 2019 Jan; 29(1):61-68.
Score: 0.575
-
Evaluation of target coverage and margins adequacy during CyberKnife Lung Optimized Treatment. Med Phys. 2018 Apr; 45(4):1360-1368.
Score: 0.573
-
Bronchiolitis obliterans organizing pneumonia after stereotactic ablative radiation therapy for lung cancer: A case report. Cancer Radiother. 2018 Feb; 22(1):57-61.
Score: 0.569
-
Salvage Stereotactic Body Radiotherapy for Isolated Lymph Node Recurrent Prostate Cancer: Single Institution Series of 94 Consecutive Patients and 124 Lymph Nodes. Clin Genitourin Cancer. 2017 08; 15(4):e623-e632.
Score: 0.529
-
Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study. World J Urol. 2019 Dec; 37(12):2631-2637.
Score: 0.154
-
Stereotactic body radiotherapy for castration-sensitive prostate cancer bone oligometastases. Med Oncol. 2018 Apr 18; 35(5):75.
Score: 0.144
-
Stereotactic ablative radiation therapy in renal cell carcinoma: From oligometastatic to localized disease. Crit Rev Oncol Hematol. 2017 Sep; 117:48-56.
Score: 0.137
-
Consensus statements on ablative radiotherapy for oligometastatic prostate cancer: A position paper of Italian Association of Radiotherapy and Clinical Oncology (AIRO). Crit Rev Oncol Hematol. 2019 Jun; 138:24-28.
Score: 0.039